Drug-drug interactions<unk>  is an inhibitor of the hepatic drug-metabolizing enzyme cytochrome P450 family 3 subfamily A member 4 (CYP3A4).<unk>  may increase the concentration of drugs that are metabolized through CYP3A4, such as the anticoagulant medication warfarin and the antiepileptic drugs phenytoin and carbamazepine. Drug-food interactions The oral absorption (bioavailability) of<unk>  is decreased by 40% when it is taken with high fat or high protein meals. To avoid this interaction,<unk>  should be taken on an empty stomach. An empty stomach is classified as an hour before, or two hours after, consuming a meal.
Zafirlukast
Pranlukast
Seratrodast
Montelukast
Levosalbutamol
Salbutamol
Lifitegrast
Pemirolast